Biofield Corp. (BZET) in $365 Million China Breast Cancer Diagnostic JV
7/2/2008 2:36:37 PM
ChinaBio Today -- Biofield Corp. established a Chinese national healthcare joint venture built around its breast cancer diagnostic device. The JV joins Biofield and Carelife, which is operating through its appointed agent, China International Medical Exchange Ltd. Funded with approximately $363 million, the Carelife JV will open a China network of medical clinics, call centers and data centers for R&D. By 2012, Carelife expects to open more than 500 medical clinics in China’s major cities. More details...
comments powered by